These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 9105872)
21. Comparison of the V1b antagonist, SSR149415, and the CRF1 antagonist, CP-154,526, in rodent models of anxiety and depression. Hodgson RA; Higgins GA; Guthrie DH; Lu SX; Pond AJ; Mullins DE; Guzzi MF; Parker EM; Varty GB Pharmacol Biochem Behav; 2007 Mar; 86(3):431-40. PubMed ID: 17291571 [TBL] [Abstract][Full Text] [Related]
22. The effect of monoamine oxidase inhibitors compared with classical tricyclic antidepressants on learned helplessness paradigm. Martin P; Soubrie P; Simon P Prog Neuropsychopharmacol Biol Psychiatry; 1987; 11(1):1-7. PubMed ID: 3602410 [TBL] [Abstract][Full Text] [Related]
23. Antidepressant-like effects of CRF1 receptor antagonist SSR125543 in an animal model of depression. Overstreet DH; Griebel G Eur J Pharmacol; 2004 Aug; 497(1):49-53. PubMed ID: 15321734 [TBL] [Abstract][Full Text] [Related]
24. Effects of the CRF(1) receptor antagonist, CP 154,526, in the separation-induced vocalization anxiolytic test in rat pups. Kehne JH; Coverdale S; McCloskey TC; Hoffman DC; Cassella JV Neuropharmacology; 2000 Jun; 39(8):1357-67. PubMed ID: 10818252 [TBL] [Abstract][Full Text] [Related]
25. Antidepressant effects of tricyclic antidepressants and selective serotonin-uptake blockers in diabetic rats. Massol J; Martin P; Puech AJ Diabetes; 1989 Sep; 38(9):1161-4. PubMed ID: 2767339 [TBL] [Abstract][Full Text] [Related]
27. Chronic administration of the selective corticotropin-releasing factor 1 receptor antagonist CP-154,526: behavioral, endocrine and neurochemical effects in the rat. Arborelius L; Skelton KH; Thrivikraman KV; Plotsky PM; Schulz DW; Owens MJ J Pharmacol Exp Ther; 2000 Aug; 294(2):588-97. PubMed ID: 10900236 [TBL] [Abstract][Full Text] [Related]
28. Recent advances with the CRF1 receptor: design of small molecule inhibitors, receptor subtypes and clinical indications. McCarthy JR; Heinrichs SC; Grigoriadis DE Curr Pharm Des; 1999 May; 5(5):289-315. PubMed ID: 10213797 [TBL] [Abstract][Full Text] [Related]
29. Dopaminergic and opioidergic mediations of tricyclic antidepressants in the learned helplessness paradigm. Besson A; Privat AM; Eschalier A; Fialip J Pharmacol Biochem Behav; 1999 Nov; 64(3):541-8. PubMed ID: 10548269 [TBL] [Abstract][Full Text] [Related]
30. Implication of endogenous opioid system in the learned helplessness model of depression. Tejedor-Real P; Mico JA; Maldonado R; Roques BP; Gibert-Rahola J Pharmacol Biochem Behav; 1995 Sep; 52(1):145-52. PubMed ID: 7501657 [TBL] [Abstract][Full Text] [Related]
31. Imipramine reverses the depressive symptoms in sepsis survivor rats. Tuon L; Comim CM; Antunes MM; Constantino LS; Machado RA; Izquierdo I; Quevedo J; Dal-Pizzol F Intensive Care Med; 2007 Dec; 33(12):2165-7. PubMed ID: 17668182 [TBL] [Abstract][Full Text] [Related]
32. Desensitization of the D1 dopamine receptors in rats reproduces a model of escape deficit reverted by imipramine, fluoxetine and clomipramine. Gambarana C; Ghiglieri O; Graziella de Montis M Prog Neuropsychopharmacol Biol Psychiatry; 1995 Sep; 19(5):741-55. PubMed ID: 8539417 [TBL] [Abstract][Full Text] [Related]
33. Pain is a salient "stressor" that is mediated by corticotropin-releasing factor-1 receptors. Hummel M; Cummons T; Lu P; Mark L; Harrison JE; Kennedy JD; Whiteside GT Neuropharmacology; 2010 Sep; 59(3):160-6. PubMed ID: 20470804 [TBL] [Abstract][Full Text] [Related]
35. The corticotropin-releasing factor1 receptor antagonist R121919 attenuates the behavioral and endocrine responses to stress. Gutman DA; Owens MJ; Skelton KH; Thrivikraman KV; Nemeroff CB J Pharmacol Exp Ther; 2003 Feb; 304(2):874-80. PubMed ID: 12538845 [TBL] [Abstract][Full Text] [Related]
36. Effects of CP 154,526, a CRF1 receptor antagonist, on behavioral responses to cocaine in rats. Przegaliński E; Filip M; Frankowska M; Zaniewska M; Papla I Neuropeptides; 2005 Oct; 39(5):525-33. PubMed ID: 16139885 [TBL] [Abstract][Full Text] [Related]
37. Differential roles of corticotropin-releasing factor receptor subtypes 1 and 2 in opiate withdrawal and in relapse to opiate dependence. Lu L; Liu D; Ceng X; Ma L Eur J Neurosci; 2000 Dec; 12(12):4398-404. PubMed ID: 11122350 [TBL] [Abstract][Full Text] [Related]
38. Treatment with escitalopram but not desipramine decreases escape latency times in a learned helplessness model using juvenile rats. Reed AL; Anderson JC; Bylund DB; Petty F; El Refaey H; Happe HK Psychopharmacology (Berl); 2009 Aug; 205(2):249-59. PubMed ID: 19387616 [TBL] [Abstract][Full Text] [Related]